Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | -0.98% |
|
+13.10% | -7.34% |
Jul. 02 | Lineage Cell Therapeutics Included in Russell 3000 Index | MT |
May. 21 | Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.34% | 191M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- Transcript : Lineage Cell Therapeutics, Inc., Q2 2021 Earnings Call, Aug 12, 2021